Netwealth (ASX:NWL) share price dips despite record results

The Netwealth (ASX:NWL) share price is on the slide today despite the company delivering a record increase to its funds under administration.

| More on:
falling asx share price represented by woman making sad face

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Netwealth Group Ltd (ASX: NWL) shares are on the slide today following the release of the company's results for the first half of the 2021 financial year (1H FY21). At the time of writing, the Netwealth share price has slumped 4.25% to $17.14.

Let's take a look at how the wealth management business has been performing.

Netwealth share price slides despite numerous highlights

The Netwealth share price has failed to ignite today despite the company reporting a record half-year increase to its funds under administration (FUA). 

Netwealth increased its FUA for the half by $7.3 billion, or around 23%, taking its total FUA as at 31 December 2020 to $38.8 billion.

For the 12 months to 31 December 2020, FUA grew to $10.3 billion, a 36.1% increase.

Earnings before interest, tax, depreciation and amortisation (EBITDA) came in at $40.5 million — an increase of 30.1% compared to the prior corresponding period (pcp). 

Netwealth's earnings per share (EPS) was 11.3 cents.

The company reported total income of $72.4 million, which represents a 23.4% increase on the prior half.

Net profit after tax (NPAT) rang in at $27.6 million, which was 34.5% or $7.1 million higher than the pcp.

The board declared a fully franked interim dividend of 9.06 cents per share totalling $22.1 million for the period. The dividend is payable on 26 March 2021.

Company outlook

Netwealth advised that its pipeline of new business and transitions remains strong.

Based on no adverse changes to the operating environment and subject to the timing of transitions, the company expects its FY21 FUA net inflows to be in the range of $8.5 billion to $9 billion.

Netwealth also expects to benefit from growth in its affluent, high net-worth and private wealth groups.

The company added 25 additional technology infrastructure resources across Australia and Vietnam during 1H FY21. The purpose of these is to build synergies with third-party software solutions providers and to continue enhancing operational efficiency and scalability.

Foolish takeaway

The Netwealth share price has gained more than 100% over the past 12 months. Netwealth shares have surged more than 200% since their March 2020 lows but are still trading around 8% lower than their 52-week high of $18.71.

Based on the current Netwealth share price, the company commands a market capitalisation of around $4.4 billion.

Motley Fool contributor Gretchen Kennedy has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Netwealth. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »